Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

por Bykerk, Vivian P, Östör, Andrew J K, Alvaro-Gracia, José, Pavelka, Karel, Ivorra, José Andrés Román, Graninger, Winfried, Bensen, William, Nurmohamed, Michael T, Krause, Andreas, Bernasconi, Corrado, Stancati, Andrea, Sibilia, Jean
Publicado 2012

Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments:...

por Bykerk, Vivian P., Östör, Andrew J. K., Alvaro-Gracia, José, Pavelka, Karel, Ivorra, José Andrés Román, Graninger, Winfried, Bensen, William, Nurmohamed, Michael T., Krause, Andreas, Bernasconi, Corrado, Aassi, Maher, Sibilia, Jean
Publicado 2015

Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous...

por Bykerk, Vivian P., Östör, Andrew J. K., Alvaro-Gracia, José, Pavelka, Karel, Ivorra, José Andrés Román, Graninger, Winfried, Bensen, William, Nurmohamed, Michael T., Krause, Andreas, Bernasconi, Corrado, Aassi, Maher, Sibilia, Jean
Publicado 2015